- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/90 - Oxygen atoms with acyclic radicals attached in position 2 or 3
Patent holdings for IPC class C07D 239/90
Total number of patents in this class: 161
10-year publication summary
|
8
|
7
|
4
|
8
|
7
|
12
|
5
|
5
|
11
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Inipharm, Inc. | 30 |
7 |
| Array BioPharma Inc. | 467 |
5 |
| ATIR Holding S.A. | 17 |
5 |
| Gilead Sciences, Inc. | 2161 |
5 |
| Hoffmann-La Roche Inc. | 3646 |
4 |
| AstraZeneca AB | 2823 |
4 |
| Southern Research Institute | 208 |
4 |
| University of Kansas | 900 |
4 |
| University of Louisville Research Foundation, Inc. | 727 |
4 |
| Novartis AG | 10467 |
3 |
| F. Hoffmann-La Roche AG | 7874 |
3 |
| AstraZeneca UK Limited | 575 |
3 |
| Pfizer Inc. | 3383 |
3 |
| Ache International (BVI) Ltd. | 6 |
3 |
| ASKA Pharmaceutical Co., Ltd. | 103 |
3 |
| Oregon Health & Science University | 754 |
3 |
| Morphic Therapeutic, Inc. | 55 |
3 |
| Amgen Inc. | 4319 |
2 |
| Sumitomo Chemical Company, Limited | 9057 |
2 |
| The Trustees of Columbia University in the City of New York | 3615 |
2 |
| Other owners | 89 |